Novel Computational and Artificial Intelligence Models in Cancer Research

Dear Colleagues, 

It is our great pleasure to announce the 13^th International Conference on Intelligent Biology and Medicine (ICIBM 2024), which will take place in Houston, TX, USA, on 10–12 October 2024. The ICIBM is a high-caliber conference that brings together high-profile keynote speakers, eminent scholars, and versatile talents with expertise in various fields of computational biology, systems biology, and computational medicine, as well as experimentalists interested in the application of computational methods in biomedical studies. The purpose of the ICIBM is to provide a congenial atmosphere that is highly conducive to extensive discussion and networking. The website of ICIBM-2024 is https://icibm2024.iaibm.org/.

You are cordially invited to submit papers with unpublished original work describing recent advances in all aspects of computational methods related to cancer research on the following topics:

• Genomics, genetics, and epigenetics, including integrative and functional genomics and genome evolution.
• Next-generation sequencing data analysis, 3D genome, applications, and software and tools.
• Big data science, including storage, analysis, modeling, visualization, and cloud computing.
• Precision medicine, translational bioinformatics, and medical informatics.
• Drug discovery, design, and re-purposing.
• Proteomics and protein structure prediction, molecular simulation, and evolution.
• Spatial transcriptomics and single-cell sequencing data analysis.
• The microbiome and metagenomics.
• Artificial intelligence, machine learning, deep learning, data mining, and knowledge discovery.
• Natural language processing, literature mining, semantic ontology, and health informatics.
• Neural computing, kernel methods, and feature selection/extraction.
• Evolutionary computing, swarm intelligence/optimization, and ensemble methods.
• Manifold learning theory, artificial life, and artificial immune systems.
• Biomedical image analysis and processing.

Dr. Shulan Tian
Dr. Jianrong Wang
Dr. Alper Uzun
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Cancers is an international peer-reviewed open access semimonthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

• ICIBM
• artificial intelligence models
• cancer research